ADVOCATE. CONNECT. INNOVATE.

Collaborations That Transform – Emerging Opportunities in Multiple Sclerosis and Neurosciences

Online

9/24/2020

7:30am - 9:30am

Dear Colleagues and Friends,

Can we build a roadmap to conquer Multiple Sclerosis (MS), a disease that impacts more than 2 million globally as the leading non-traumatic disability disorder in young adults? How have lessons learnt so far shed light on broader neuroscience R&D?

On September 24, join us for “Emerging Opportunities in Multiple Sclerosis and Neurosciences,” the fourth episode in our “Collaborations That Transform” webinar series.

AGENDA (Eastern Daylight Time)

10:30 Welcome

Hui Cai, VP and Head of Content, WuXi AppTec, Program Chair

10:30 – 10:50 Session I: Meeting the Challenges in MS and Neuroscience Drug Development

A conversation with Dietmar Berger, Head of Development and CMO, Sanofi; moderated by Kevin Da Silva, Chief Editor, Nature Neuroscience

10:50 – 11:35 Session II: Clinical Prospects for a Challenging Disease: MS

Mark Freedman, Professor of Neurology, University of Ottawa; Sr. Scientist, The Ottawa Hospital Research Institute

Ari Green, Chief, Division of Neuroinflammation and Glial Biology, Medical Director, Multiple Sclerosis and Neuroinflammation Center, UCSF

Tanuja Chitnis, Professor of Neurology, Harvard Medical School

Cyndi Zagieboylo, President and CEO, National MS Society

Moderated by Mandy Jackson, Managing Editor of US Commercial News for Scrip and The Pink Sheet

11:35 – 12:30 Session III: New Directions in MS Therapies

Ralph Kern, President and Chief Medical Officer, Brainstorm Cell Therapeutics

Dan Lorrain, Chief Scientific Officer, Pipeline Therapeutics

Joachim Herz, Professor, Molecular Genetics, Neuroscience, Neurology; Director, Center for Translational Neurodegeneration Research, UT Southwestern Medical Center

Krish Ramanathan, Global Program Head, Neuroscience and Global Drug Development, Novartis

Moderated by Richard Soll, Head of WuXi AppTec’s Boston office; Senior Advisor of Strategic Initiatives

12:30 Closing

As an industry enabler, WuXi AppTec is committed to improving the lives of patients globally. We share the conviction that we must work collaboratively to solve industry-wide challenges and bring transformative medicines to patients.

This event is complimentary and open to the public. We welcome you to the conversation.

Click Here for More Information

Contact: Peter Zhu
Contact Email: huichun_zhu@wuxiapptec.com